• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

Asian shares stem recent losses, attention on cenbank tapering

September 10, 2021 by David Barret Leave a Comment

September 10, 2021

By Alun John

HONG KONG (Reuters) – Asian shares rallied on Friday after two days of losses, but were still in a nervous mood as global investors grapple with how best to interpret central banks’ cautious moves to end stimulus, which also left currency markets quiet.

MSCI’s broadest index of Asia-Pacific shares outside Japan, gained 0.47% in early trading, but is still down around 0.8% compared to last week’s close, in line with the global trend.

Japan’s Nikkei rose 0.25%, and U.S. stock futures, the S&P 500 e-minis, were flat.

Australia gained 0.4% as mining stocks rose after aluminium prices hit multi-year highs, and Chinese blue chips also advanced 0.5%

But gains were lead by Hong Kong with the local benchmark rebounding 1.5% having fallen over 2% the day before when Chinese tech stocks took another battering after authorities called gaming firms in for a word. But traders are still cautious about buying too much of the dip.

“At some point in time investors will say actually this is the right price, it’s not going to go to zero,” said John Lau, head of Asian equities and a senior portfolio manager at SEI, referring to Chinese tech names.

“I think most investors will wait until the dust settles and see whether is there is enough clarity before they can act, at this point in time its extremely difficult.”

Asian gains followed a wobbly Thursday when markets had struggled to gain clear direction.

Reaction to the European Central Bank saying over the coming quarter it would slow emergency bond purchases implemented during the COVID-19 pandemic was constrained by the ECB refraining from detailing how it plans to end its 1.85-trillion-euro Pandemic Emergency Purchase Programme.

“Risk sentiment flip-flopped through the overnight session, initially reacting positively to the ECB meeting and evidence of ongoing strength in the U.S. labour market. However, U.S. equities ended in the red, likely reflecting concerns about the timing of central bank tapering and ongoing Delta woes,” said analysts at ANZ.

The Dow Jones Industrial Average fell 0.43%, the S&P 500 lost 0.46%, and Nasdaq Composite dropped 0.25%.

Investors normally interpret better employment figures as a sign the Federal Reserve is less likely to delay trimming its massive asset purchases, which have been supporting share prices in recent months.

In addition, Federal Reserve Bank Governor Michelle Bowman added her voice to the growing number of policymakers who say the weak August jobs report likely won’t throw off the central bank’s plan to trim its $120 billion in monthly bond purchases later this year.

In currency markets, the euro was flat in Asian hours at $1.1820, after the ECB announcement helped it stem a few days of losses, as it fell off its month high set at the end of last week.

The dollar was also little changed against a basket of peers but on course for nearly a 0.5% weekly rise.

The yield on benchmark 10-year Treasury notes edged up to 1.307% compared with its U.S. close of 1.3%.

U.S. crude dipped 0.1% to $68 a barrel. Brent crude fell 0.15% to $71.34 per barrel.

(Editing by Lincoln Feast)

Source Link Asian shares stem recent losses, attention on cenbank tapering

David Barret
David Barret

Related posts:

  1. U.S. has identified a small number of Americans in Mazar-i-Sharif -Blinken
  2. Qatar and Turkey working to restore Kabul passenger flights, ministers say
  3. Canada’s Trudeau hit by gravel on campaign trail dogged by anti-vax hecklers
  4. Box Office: Marvel’s ‘Shang-Chi’ Crushes Labor Day Weekend Records With $90 Million

Filed Under: News

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

  • Carl Sagan Left A Heartfelt Message For The First People To Set Foot On Mars
  • People Are Just Learning About A Key Feature Of The Statue Of Liberty That Everyone Forgets
  • Lupus Linked To Virus That Over 95 Percent Of Us Carry, First Radio Detection Received From Interstellar Object 3I/ATLAS, And Much More This Week
  • Why Do Cars Have Those Lines On The Rear Window?
  • SpaceX CEO Elon Musk Responds To Wild Speculation That 3I/ATLAS Is An Alien Spaceship
  • Did NASA’s Viking Mission Find Evidence Of Extant Life On Mars? It’s Not As Out There As It Sounds
  • World’s Oldest RNA Recovered From Baby Mammoth Beautifully Preserved In Permafrost For 40,000 Years
  • No Mining, No Machines – How The Future Of Technology Depends On Greener Mines
  • “It Was A Huge Surprise”: Dinosaur Eggs Were Speckled And Colorful, Just Like Birds’ Eggs
  • Meet The Peacock Spiders: Secretive, Small But Oh So Special
  • “Sudden Unexplained Death” In US Turns Out To Be World’s First Confirmed Death From Tick-Spread “Meat Allergy”
  • What’s The Longest Border In The World? It’s A Lot Weirder Than It Looks On A Map
  • “The Fall Of Icarus”: You Have Never Seen An Astrophotography Picture Like This!
  • Blue Origin Sends NASA Mission To Mars, Followed By First-Ever Successful Landing Of New Glenn’s Booster
  • This 4,300-Year-Old Silver Goblet May Contain Earliest Known Depiction Of Cosmic Genesis
  • Filter-Feeding Pterosaur Becomes The First Extinct Species Discovered In Fossil Vomit
  • We Jinxed It – Golden Comet C/2055 K1 (ATLAS) Has Now Broken Into Pieces
  • This Plant Hoards Rare Earth Elements That The World Desperately Needs
  • Lupus Linked To Virus That Over 95 Percent Of Us Carry – And Now We Finally Know How
  • This Whale’s Meal Plan? Over 70,000 Squid A Year, And It’ll Dive Incredible Depths To Get Them
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2025 · Medical Market Report. All Rights Reserved.

Go to mobile version